About the Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. Session
Liquid biopsies represent a revolutionary approach to cancer diagnostics, offering a non-invasive alternative to tissue biopsies. By analyzing circulating tumor DNA (ctDNA), exosomes, and other biomarkers in blood, liquid biopsies enable early detection, real-time monitoring, and treatment adjustments. They are particularly valuable for cancers with challenging biopsy procedures, such as pancreatic and lung cancers. Research focuses on enhancing sensitivity and specificity, developing multi-cancer detection platforms, and integrating liquid biopsies into routine care. These advancements hold immense potential to transform cancer management, offering hope for improved outcomes.
Topics Covered in Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring.
Circulating Tumor DNA
Circulating Tumor Cells
Extracellular Vesicles
Multi-Cancer Early Detection
Minimal Residual Disease
Sensitivity & Specificity
Related Scientific Sessions at CIOC 2027
Why Attend the Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. Conference 2027 — FAQs
What is the Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. track at CIOC 2027?
The Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring.. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. sessions?
Cancer researchers and clinicians, educators and students with an interest in Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. are all welcome — whether presenting or attending.
Can I present my research in the Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring. track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.